CLDX Stock-Based Compensation
Celldex Therapeutics Inc · Stock-Based Compensation
CLDX Stock-Based Compensation
Latest reported$34.64Mperiod ending
CLDX TTM Stock-Based Comp ($0.00 → $34.64M)
TTM stock-based compensation
High-resolution chart · PNG
CLDX stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 34,641,000 | |
| 35,424,000 | |
| 36,217,000 | |
| 37,088,000 | |
| 37,907,000 | |
| 36,356,000 | |
| 34,242,000 | |
| 31,674,000 | |
| 29,175,000 | |
| 26,752,000 | |
| 23,890,000 | |
| 21,186,000 | |
| 18,561,000 | |
| 16,798,000 | |
| 15,611,000 | |
| 14,243,000 | |
| 12,776,000 | |
| 10,831,000 | |
| 8,953,000 | |
| 7,070,000 | |
| 5,291,000 | |
| 4,503,000 | |
| 3,915,000 | |
| 3,345,000 | |
| 2,802,000 | |
| 3,545,000 | |
| 4,551,000 | |
| 5,616,000 | |
| 6,702,000 | |
| 7,286,000 | |
| 8,081,000 | |
| 8,913,000 | |
| 9,859,000 | |
| 11,261,000 | |
| 12,312,000 | |
| 13,336,000 | |
| 14,393,000 | |
| 14,916,000 | |
| 15,317,000 | |
| 15,806,000 | |
| 15,879,000 | |
| 14,433,000 | |
| 12,774,000 | |
| 10,810,000 | |
| 8,899,000 | |
| 7,883,000 | |
| 6,852,000 | |
| 5,867,000 | |
| 5,925,000 | |
| 5,090,000 | |
| 4,548,000 | |
| 4,084,000 | |
| 2,594,000 | |
| 2,365,000 | |
| 2,298,000 | |
| 2,253,000 | |
| 2,297,000 | |
| 2,403,000 | |
| 2,342,000 | |
| 2,308,000 | |
| 2,321,000 | |
| 2,412,000 | |
| 2,802,000 | |
| 2,773,000 | |
| 2,808,000 | |
| 2,915,530 | |
| 3,058,000 | |
| 2,482,000 | |
| 1,864,000 | |
| 1,112,470 | |
| 1,622,380 | |
| 361,165,380 | |
| 361,165,380 | |
| 361,165,380 | |
| 359,641,897 | |
| 1,626,854,897 | |
| 1,626,854,897 | |
| 1,626,854,897 | |
| 1,627,020,255 | |
| 538,264,255 | |
| 538,264,255 | |
| 538,264,255 | |
| 538,121,000 | |
| 328,121,000 | |
| 328,121,000 | |
| 328,121,000 | |
| 328,000,000 | |
| 115,000,000 | |
| 115,000,000 | |
| 115,000,000 | |
| 115,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |